The Effect of Teprotumumab on Ocular Surface Symptoms in Thyroid Eye Disease

被引：0
|
作者：
Cale, Mario [1 ]
Osias, Ethan [1 ]
Singh, Pallavi [1 ]
Rootman, Daniel [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Orbital & Ophthalm Plast Surg, Los Angeles, CA 90095 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3997 - A03
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Teprotumumab for the treatment of chronic thyroid eye disease
    Ugradar, Shoaib
    Kang, Julia
    Kossler, Andrea L.
    Zimmerman, Erin
    Braun, Jenna
    Harrison, Andrew R.
    Bose, Swaraj
    Cockerham, Kimberly
    Douglas, Raymond S.
    EYE, 2022, 36 (08) : 1553 - 1559
  • [22] Teprotumumab for Optic Neuropathy in Thyroid Eye Disease
    Slentz, Dane H.
    Smith, Terry J.
    Kim, Denise S.
    Joseph, Shannon S.
    JAMA OPHTHALMOLOGY, 2021, 139 (02) : 244 - 247
  • [23] The knowns and unknowns of teprotumumab for thyroid eye disease
    Bednarczuk, Tomasz
    Pearce, Simon H.
    LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (06): : 323 - 325
  • [24] Ocular Surface Changes in Thyroid Eye Disease
    Ismailova, Dilyara S.
    Fedorov, Anatoly A.
    Grusha, Yaroslav O.
    ORBIT-AN INTERNATIONAL JOURNAL ON ORBITAL DISORDERS AND FACIAL RECONSTRUCTIVE SURGERY, 2013, 32 (02): : 87 - 90
  • [25] Severe Hyperglycemia with Teprotumumab for Treatment of Thyroid Eye Disease
    Cottom, Savannah
    Barrientez, Brayden
    Melson, Andrew
    CASE REPORTS IN OPHTHALMOLOGY, 2024, 15 (01): : 246 - 249
  • [26] Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease
    Rachmasari, Kharisa N.
    Toro-Tobon, David
    Wagner, Lilly H.
    Tooley, Andrea A.
    Bradley, Elizabeth A.
    Stan, Marius N.
    ENDOCRINE PRACTICE, 2024, 30 (10) : 937 - 942
  • [27] Teprotumumab for Thyroid Eye Disease-related Strabismus
    Dallalzadeh, Liane O.
    Villatoro, George A.
    Chen, Lillian
    Sim, Myung S.
    Movaghar, Mansoor
    Robbins, Shira L.
    Karlin, Justin N.
    Khitri, Monica R.
    Velez, Federico G.
    Korn, Bobby S.
    Demer, Joseph L.
    Rootman, Daniel B.
    Granet, David B.
    Kikkawa, Don O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (04): : 434 - 439
  • [28] Teprotumumab (Tepezza)-related hyperglycemia in thyroid eye disease
    Lang, Tracy
    Rael, Aaron
    Park, Kristen
    Sudharshan, Rasika
    Chang, Jessica R.
    Zhang-Nunes, Sandy
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [29] Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease
    Al-Sharif, Eman M.
    Zhou, Jason
    Shoji, Marissa K.
    Acuff, Kaela
    Liu, Catherine Y.
    Korn, Bobby S.
    Kikkawa, Don O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2025, 41 (01): : 22 - 27
  • [30] Teprotumumab, a Novel Biologic for Active Thyroid Eye Disease
    Kahaly, George.
    Sile, Saba
    Thompson, Elizabeth H.
    Vescio, Thomas
    Perdok, Renee
    Sherman, Jeffrey W.
    Smith, Terry J.
    Douglas, Raymond S.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345